Sesti F, Mantenuto L, Ciancaglini G, Zupi E, Terenzi S, Piccione E
G Ital Oncol. 1989 Oct-Dec;9(4):121-4.
In the present work, on the basis of the most recent knowledges, the Authors analyse and discuss the pharmacological and clinical aspects of the different types of second-line chemotherapeutical treatment for refractory ovarian cancer (standard single agent chemotherapy in high-dose schedules, new investigational anticancer agents, multidrugs chemotherapy, intraperitoneal chemotherapy).
在本研究中，基于最新知识，作者分析并讨论了难治性卵巢癌不同类型二线化疗的药理学和临床方面（高剂量方案的标准单药化疗、新型研究性抗癌药物、多药化疗、腹腔内化疗）。
